Astellas Pharma Reports - Industry Research

Carbonated Beverages Market Major Players

Cancer Immunotherapy Market

The cancer immunotherapy market is projected to register a CAGR of 9.1% during the forecast period of 2022-2027.

Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market

The Sodium-dependent Glucose Co-transporter 2 Market size is estimated at USD 11.42 billion in 2024, and is expected to reach USD 17.32 billion by 2029, growing at a CAGR of 8.68% during the forecast period (2024-2029).

Japan Oral Anti-Diabetic Drug Market

The Japan Oral Anti-Diabetic Drug Market size is estimated at USD 2.42 billion in 2024, and is expected to reach USD 3.02 billion by 2029, growing at a CAGR of 4.60% during the forecast period (2024-2029).

Italy Oral Anti-Diabetic Drug Market

The Italy Oral Anti-Diabetic Drug Market size is estimated at USD 705.48 million in 2024, and is expected to reach USD 837.88 million by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).

India Oral Anti-Diabetic Drug Market

The India Oral Anti-Diabetic Drug Market size is estimated at USD 1.7 billion in 2024, and is expected to reach USD 2.01 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).

New Zealand Oral Anti-Diabetic Drug Market

The New Zealand Oral Anti-Diabetic Drug Market size is estimated at USD 323 million in 2024, and is expected to reach USD 367.23 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029).

Europe Oral Anti-Diabetic Drug Market

The Europe Oral Anti-Diabetic Drug Market size is estimated at USD 7.36 billion in 2024, and is expected to reach USD 8.70 billion by 2029, growing at a CAGR of 3.40% during the forecast period (2024-2029).

Asia-Pacific Oral Anti-Diabetic Drug Market

The Asia-Pacific Oral Anti-Diabetic Drug Market size is estimated at USD 25.37 billion in 2024, and is expected to reach USD 29.56 billion by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).

Mexico Oral Anti-Diabetic Drug Market

Mexico's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period, with revenue of USD 1.5 billion in the current year.

Brazil Oral Anti-Diabetic Drug Market

The Brazil Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period, with revenue of USD 861 million in the current year.

Malaysia Oral Anti-Diabetic Drug Market

The Malaysia Oral Anti-Diabetic Drug Market is expected to register a CAGR of over 3% during the forecast period.

South Korea Oral Anti-Diabetic Drug Market

South Korea Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period and 506 million in revenue in the forecast period.

France Oral Anti-Diabetic Drug Market

France's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period and revenue of USD 0.7 billion in the current year.

Vietnam Oral Anti-Diabetic Drug Market

The Vietnam Oral Anti-Diabetic Drug Market size is estimated at USD 156.21 million in 2024, and is expected to reach USD 195.32 million by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).

Indonesia Oral Anti-Diabetic Drug Market

The Indonesia Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period and USD 202 million in revenue in the current year.

Philippines Oral Anti-Diabetic Drug Market

The Philippines Oral Anti-Diabetic Drug Market size is estimated at USD 202.20 million in 2024, and is expected to reach USD 251.32 million by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).

Thailand Oral Antidiabetic Drug Market

Thailand's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 6% during the forecast period and 68 million in revenue in the current year.

South Africa Oral Antidiabetic Drug Market

The South Africa Oral Antidiabetic Drug Market size is estimated at USD 241.78 million in 2024, and is expected to reach USD 275.36 million by 2029, growing at a CAGR of greater than 2% during the forecast period (2024-2029).

Oral Anti-Diabetic Drugs Market

The Oral Anti-Diabetic Drugs Market size is estimated at USD 46.82 billion in 2024, and is expected to reach USD 57.44 billion by 2029, growing at a CAGR of 4.17% during the forecast period (2024-2029).

Overactive Bladder Treatment Market

The overactive bladder (OAB) treatment market is expected to register a CAGR of 3.4% over the forecast period.

North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market

The North America Sodium-Dependent Glucose Co-Transporter 2 Market size is estimated at USD 7.39 billion in 2024, and is expected to reach USD 10.99 billion by 2029, growing at a CAGR of 8.67% during the forecast period (2024-2029).

Liver Diseases Therapeutics Market

During the forecast period, the market for medicines to treat liver disease is expected to register a CAGR of about 8.5%.

Myasthenia Gravis Therapeutics Market

Myasthenia gravis (MG) is a long-term neuromuscular disease that leads to varying degrees of skeletal muscle weakness.

Pompe Disease Market

The Pompe disease market is expected to register a CAGR of 4.5% over the forecast period.

Androgen Deprivation Therapy Market

The Androgen Deprivation Therapy Market is expected to register a significant CAGR of 5.2% during the study period.

Global Tacrolimus Market

The tacrolimus market is expected to register a CAGR of 5.2% over the forecast period, 2022-2027.

MEA Cancer Vaccines Market

The Middle East and Africa cancer vaccine market is expected to register a CAGR of 9.6% during the forecast period.

MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market

The MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market size is estimated at USD 165.5 million in 2024, and is expected to reach USD 256.40 million by 2029, growing at a CAGR of 9.15% during the forecast period (2024-2029).

Benign Prostatic Hyperplasia Market

The benign prostatic hyperplasia market is expected to register a CAGR of nearly 8.5% during the forecast period (2022-2027).

Global Cholera Vaccines Market

The cholera vaccines market is poised to grow at a CAGR of 9.8% over the forecast period.

Cryptococcosis Therapeutics Market

Cryptococcosis is a fungal infection which is caused by Cryptococcus neoformans and Cryptococcus gattii which primarily affects the central nervous system and the lungs.

Global Immunosuppressant Drugs Market

The immunosuppressant drugs market is expected to register a CAGR of 4.6% during the forecast period.

Latin America Oral Anti-Diabetic Drug Market

The Latin America Oral Anti-Diabetic Drug Market size is estimated at USD 3.25 billion in 2024, and is expected to reach USD 3.86 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).

North America Cancer Vaccines Market

The North America Cancer Vaccines Market is expected to grow with a CAGR of 12.2% in the forecast period.

Candidiasis Therapeutics Market

The candidiasis therapeutics market is expected to register a CAGR of 5.1% over the forecast period.

Organ Transplant Immunosuppressant Drugs Market

The organ transplant immunosuppressant drugs market is expected to register a CAGR of 3.5% during the forecast period.

Global Immunomodulators Market

The immunomodulators market is expected to register a CAGR of 5.4% over the forecast period 2022-2027.

Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market

The Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market size is estimated at USD 0.3 billion in current year, and is expected to reach USD 0.5 billion by forecast period, growing at a CAGR of 9% during the forecast period.

Astellas Pharma Reports - Industry Research

Reports Featuring Astellas Pharma

Other Reports Covering Astellas Pharma

Industries Astellas Pharma Operates Within:

Astellas Pharma Competitors